Search Nonprofits

AFTD’s mission is to improve the quality of life of people affected by FTD and drive research to a cure. We work every day to advance: Research. We promote and fund research toward diagnosis, treatment and a cure. Awareness. We stimulate greater public awareness and understanding. Support. We provide information and support to those directly impacted. Education. We promote and provide education for healthcare professionals. Advocacy. We advocate for research and appropriate, affordable services.

Our mission is to find a effective treatments and ultimately a cure for fragile X syndrome, the most common inherited cause of autism. We directly fund research grants and fellowships at top universities around the world. FRAXA was founded in 1994 by three parents of children with fragile X. Fragile X Syndrome is the most common inherited cause of autism and intellectual disabilities. It affects 1 in 4000 boys and 1 in 6000 girls worldwide, and one in 260 women and 1 in 800 men are carriers. Treatments for fragile X are likely to help people affected by related disorders including autism, Alzheimers, and many other brain disorders.

The Pacific Mesothelioma Center at the Pacific Heart, Lung and; Blood Institute’s mission is to better serve a growing number of mesothelioma victims by supporting the first-of-its-kind in the nation research lab which provides laboratory-to-the-bedside research that improve mesothelioma victims’ lives and longevity, particularly for those that approach malignant pleural mesothelioma (MPM) as a chronic, treatable disease: The exploration of innovative ideas forms the foundation of PMC’s unique research program and provides the promise of future treatment breakthroughs. With the opening of our new laboratory at 10780 Santa Monica, dedicated solely to mesothelioma research, and by choosing specific projects, we will get closer to finding better treatments and research that we hope will eventually lead to a cure. PMC is dedicated to educating the public on asbestos-related diseases and informing them of their best treatment options. PMC also connects newly diagnosed patients with patients that have been through treatment and provides assistance and emotional support.

The Fisher Center for Alzheimer’s Research Foundation is an organization that provides millions of dollars for novel Alzheimer’s research all over the world to investigate the latest, most promising research available. Our mission is to understand the causes of Alzheimer’s disease, improve the care of people living with it, and find a cure. A majority of our funding goes to the Fisher Center Lab at The Rockefeller University that was under the direction of the late Nobel laureate Dr. Paul Greengard, which is now under the leadership of Dr. Nathaniel Heintz. The Center has provided researchers around the globe with a conceptual framework for understanding the disease process and continues to be at the forefront of one day finding a cure for Alzheimer’s disease. We also fund research at NYU Langone, where a handful of clinical trials are taking place. The Foundation’s national comprehensive Alzheimer’s Information Program, the heart of which is the Foundation’s website, www.ALZinfo.org continues to spearhead efforts to increase awareness of and education about Alzheimer’s disease to the general public. The website provides in-depth information on the most current research studies, treatments, and disease management approaches. We also publish a magazine (Preserving Your Memory®) that provides readers with information about Alzheimer’s and how to take the necessary steps to prepare adequately if they or a loved one fall victim to the disease. Another facet of our Information Program is the e-newsletter, which contains updates and helpful tips. Our vision is working towards a future where Alzheimer’s is nothing but a memory.